Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Astellas Pharma Inc.
Scientific Title
An Open-label, Randomized, Controlled Phase 3 Study of Enfortumab Vedotin in Combination With Pembrolizumab Versus Chemotherapy Alone in Previously Untreated Locally Advanced or Metastatic Urothelial Cancer